Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Business & Finance › Retire on 8% a year with little or no risk? How to use...
Business & Finance

Retire on 8% a year with little or no risk? How to use annuities the right way.

Retire on 8% a year with little or no risk? How to use annuities the right way.
MarketWatch Friday 23 October 2026, 15:56 UTC By Brett Arends 1 min read
Key Points

Market turmoil has created a remarkable opportunity in recent weeks for retirees and those seeking secure, stable income for life.

Market turmoil has created a remarkable opportunity in recent weeks for retirees and those seeking secure, stable income for life.
Originally published by MarketWatch Read original →

Related Stories

Walmart, Best Buy and other stores now use digital price tags. Critics say they could lead to different prices for different shoppers.

Store aisles are getting a digital makeover.

MarketWatch 18m ago

Stocks mixed, day after AI-related selloff; oil prices rise again

Stocks mixed, day after AI-related selloff; oil prices rise again NEW YORK/LONDON, Oct 23 : Stock indexes were mixed on Friday, with tech shares edging higher after the previous day's selloff, while Brent crude oil rose to its highest in more than five months after Houthi attacks in Saudi Arabia. The Nasdaq was up 0.2 per cent after starting the day lower, while the Dow was last down about 1 per cent. An index of semiconductors was up about 1 per cent.

Channel News Asia 21m ago

Sources: Devils in advanced talks to acquire G Hellebuyck from Jets

The New Jersey Devils are in advanced talks to acquire goaltender Connor Hellebuyck from the Winnipeg Jets, sources told ESPN on Friday. As recently as last weekend, the Jets were underwhelmed by the trade offers they had received for Hellebuyck, sources said. However, negotiations gained significant momentum Thursday night, with New Jersey emerging as a serious contender to land the star goaltender.

ESPN 25m ago

Doctors call Moderna, Merck cancer vaccine data a major advancement — despite Wall Street reaction

Leaked confidential data. A major stock sell-off. Beneath the chaos surrounding Moderna and Merck's latest data on their personalized cancer vaccine, oncologists see something else: an important milestone in melanoma treatment.

CNBC 34m ago